organid,organ,t,n,m,region
1,Urinary Bladder,"TX Primary tumor cannot be assessed
T0 No evidence of primary tumor
Ta Noninvasive papillary carcinoma
Tis Carcinoma in situ: ﾓflat tumorﾔ
T1 Tumor invades subepithelial connective tissue
T2 Tumor invades muscularis propria
pT2a Tumor invades superficial muscularis propria (inner half)
pT2b Tumor invades deep muscularis propria (outer half)
T3 Tumor invades perivesical tissue
pT3a Microscopically
pT3b Macroscopically (extravesical mass)
T4 Tumor invades any of the following: prostatic stroma, seminal vesicles, uterus, vagina, pelvic wall, abdominal wall
T4a Tumor invades prostatic stroma, uterus, vagina
T4b Tumor invades pelvic wall, abdominal wall","NX Lymph nodes cannot be assessed
N0 No lymph node metastasis
N1 Single regional lymph node metastasis in the true pelvis (hypogastric, obturator, external iliac, or presacral lymph node)
N2 Multiple regional lymph node metastasis in the true pelvis (hypogastric, obturator, external iliac, or presacral lymph node metastasis)
N3 Lymph node metastasis to the common iliac lymph nodes","MX - Distant metastasis (M) cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis",Genitourinary
2,Lung,"Tx - The tumor size is unknown, or cancer cells are only found in sputum.
T0 - There is no evidence of a primary tumor.
Tis - Carcinoma in situ – The tumor is present only in the cells lining the airway.
T1 – Tumors less than or equal to 3 cm 
 T1a – Less than or equal to 2 cm. 
 T1b – Greater than 2 cm but less than or equal to 3 cm.
T2 – The tumor is greater than 3 cm but less than 7 cm. T2 tumors may block part of the airway, but have not resulted in pneumonia or caused atelectasis. They may have spread to the lining around the lungs. They may also be close to the main bronchus, but are at least 2 cm (about an inch) away from the area in which the bronchus divides to go to each of the lungs. 
 T2a - Greater than 3 cm but less than or equal to 5 cm. 
 T2b - Greater than 5 cm but less than or equal to 7 cm.

T3 - Tumors greater than 7 cm, or less than 7 cm but with a separate nodule in the same lobe. T3 tumors also include tumors that are less than 7 cm but invade the lining of the lung (pleura), the chest wall, the diaphragm, the main bronchus, or lie within 2 cm of the area where the bronchus divides to travel to the lungs. A tumor is also classified as T3 if it is less than 7 cm but is associated with pneumonia or collapse of the entire lung.

T4 - A tumor of any size, but with another nodule in a different lobe on the same side of the body, or a tumor that invades structures in the chest such as the heart, major blood vessels near the heart, the trachea, the recurrent laryngeal nerve (a nerve near the trachea), the mediastinum (the space between the lungs), the esophagus, or the area where the main bronchus divides to travel to the two lungs.","NX Regional lymph nodes cannot be assessed
N0 No regional node metastasis
N1 Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension
N2 Metastasis in the ipsilateral mediastinal and/or subcarinal lymph node(s)
N3 Metastasis in the contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes ","MX - Distant metastasis (M) cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis",Chest
3,Mesothelioma,"TX Primary tumor cannot be assessed
T0 No evidence of primary tumor
T1 Tumor limited to the ipsilateral parietal pleura with or without mediastinal pleura and with or without diaphragmatic pleural involvement
T1a No involvement of the visceral pleura
T1b Tumor also involving the visceral pleura
T2 Tumor involving each of the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least 1 of the following:
    Involvement of the diaphragmatic muscle
    Extension of tumor from the visceral pleura into the underlying pulmonary parenchyma

T3 Locally advanced but potentially resectable tumor; tumor involving all of the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least 1 of the following:
    Involvement of the endothoracic fascia
    Extension into the mediastinal fat
    Solitary, completely resectable focus of tumor extending into the soft tissue of the chest wall
    Nontransmural involvement of the pericardium

T4 Locally advanced, technically unresectable tumor; tumor involving all of the ipsilateral pleural surfaces (parietal, mediastinal, diaphragmatic, and visceral pleura) with at least 1 of the following:
    Diffuse extension or multifocal masses of tumor in the chest wall, with or without associated rib destruction
    Direct diaphragmatic extension of the tumor to the peritoneum
    Direct extension of the tumor to the contralateral pleura
    Direct extension of the tumor to a mediastinal organ
    Direct extension of the tumor into the spine
    Tumor extending through to the internal surface of the pericardium with or without a pericardial effusion or tumor involving the myocardium ","NX Regional lymph node(s) cannot be assessed
N0 No regional lymph node metastases
N1 Metastases in the ipsilateral bronchopulmonary or hilar lymph node
N2 Metastases in the subcarinal or in the ipsilateral mediastinal lymph node, including the ipsilateral internal mammary and peridiaphragmatic nodes
N3 Metastases in the contralateral mediastinal, contralateral internal mammary, ipsilateral or contralateral supraclavicular lymph nodes ","MX - Distant metastasis (M) cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis",Chest
4,Stomach,"Tx -  Primary tumor (T) cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ, intraepithelial tumor without invasion of lamina propria
T1 - Tumor invades lamina propria or submucosa
T2 - Tumor invades muscularis propria or subserosa
T3 - Tumor penetrates serosa (ie, visceral peritoneum) without invasion of adjacent structures
T4 - Tumor invades adjacent structures","NX - Regional lymph nodes (N) cannot be assessed
N0 - No regional lymph node metastases
N1 - Metastasis in 1-6 regional lymph nodes
N2 - Metastasis in 7-15 regional lymph nodes
N3 - Metastasis in > 15 regional lymph nodes","MX - Distant metastasis (M) cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis",Digestive system
5,Anal,"TX Primary tumor cannot be assessed
T0 No evidence of primary tumor
Tis Carcinoma in situ (Bowen disease, high-grade squamous intraepithelial lesion [HSIL], anal intraepithelial neoplasia II-III (AIN II-III)
T1 Tumor 2 cm or less in greatest dimension
T2 Tumor more than 2 cm but not more than 5 cm in greatest dimension
T3 Tumor more than 5 cm in greatest dimension
T4 Tumor of any size invades adjacent organ(s) (eg, vagina, urethra, bladder);direct invasion of the rectal wall, perirectal skin, subcutaneous tissue, or the sphincter muscle(s) is not classified as T4 ","NX Regional lymph nodes cannot be assessed
N0 No regional lymph node metastasis
N1 Metastasis in perirectal lymph node(s)
N2 Metastasis in unilateral internal iliac and/or inguinal lymph node(s)
N3 Metastasis in perirectal and inguinal lymph nodes and/or bilateral internal iliac and/or inguinal lymph nodes","MX - Distant metastasis (M) cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis",Digestive system
6,Esophagus,"TX Primary tumor cannot be assessed
T0 No evidence of primary tumor
Tis High-grade dysplasia
T1 Tumor invades lamina propria, muscularis mucosae, or submucosa
T1a Tumor invades lamina propria or muscularis mucosae
T1b Tumor invades submucosa
T2 Tumor invades muscularis propria
T3 Tumor invades adventitia
T4 Tumor invades adjacent structures
T4a Resectable tumor invading pleura, pericardium, or diaphragm
T4b Unresectable tumor invading other adjacent structures, such as the aorta, vertebral body, and trachea","NX Regional lymph node(s) cannot be assessed
N0 No regional lymph node metastasis
N1 Metastasis in 1-2 regional lymph nodes
N2 Metastasis in 3-6 regional lymph nodes
N3 Metastasis in 7 or more regional lymph nodes","MX - Distant metastasis (M) cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis",Digestive system
7,Colorectal,"
TX - Primary tumor cannot be assessed 
T0 - No evidence of primary tumor 
Tis - Carcinoma in situ: intraepithelial or invasion of lamina propria 
T1 - Tumor invades submucosa 
T2 - Tumor invades muscularis propria 
T3 - Tumor invades through the muscularis propria into the pericolorectal tissues 
T4a - Tumor penetrates to the surface of the visceral peritoneum 
T4b - Tumor directly invades or is adherent to other organs or structures 

","
NX - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1-3 regional lymph nodes
N1a - Metastasis in 1 regional lymph node
N1b - Metastasis in 2-3 regional lymph nodes
N1c - Tumor deposit(s) in the subserosa, mesentery, or nonperitonealized pericolic or perirectal tissues without regional nodal metastasis 
N2 - Metastasis in 4 or more lymph nodes
N2a - Metastasis in 4-6 regional lymph nodes
N2b - Metastasis in 7 or more regional lymph nodes
","M0 - No distant spread seen
M1a - Spread to 1 distant organ or set of distant lymph nodes
M1b - Spread to > 1 distant organ or set of distant lymph nodes, or has spread to distant parts of the peritoneum ",Digestive system
8,Prostate,"
TX: cannot evaluate the primary tumor
T0: no evidence of tumor
T1: tumor present, but not detectable clinically or with imaging
        T1a: tumor was incidentally found in less than 5% of prostate tissue resected (for other reasons)
        T1b: tumor was incidentally found in greater than 5% of prostate tissue resected
        T1c: tumor was found in a needle biopsy performed due to an elevated serum PSA
T2: the tumor can be felt (palpated) on examination, but has not spread outside the prostate
        T2a: the tumor is in half or less than half of one of the prostate gland's two lobes
        T2b: the tumor is in more than half of one lobe, but not both
        T2c: the tumor is in both lobes but within the prostatic capsule
T3: the tumor has spread through the prostatic capsule (if it is only part-way through, it is still T2)
        T3a: the tumor has spread through the capsule on one or both sides
        T3b: the tumor has invaded one or both seminal vesicles
T4: the tumor has invaded other nearby structures
","NX: cannot evaluate the regional lymph nodes
N0: there has been no spread to the regional lymph nodes
N1: there has been spread to the regional lymph nodes
","MX: cannot evaluate distant metastasis
M0: there is no distant metastasis
M1: there is distant metastasis
        M1a: the cancer has spread to lymph nodes beyond the regional ones
        M1b: the cancer has spread to bone
        M1c: the cancer has spread to other sites (regardless of bone involvement)
",Genitourinary
9,Breast,"TX- that the tumour size cannot be assessed

Tis - DCIS
T1 – The tumour is 2 centimetres (cm) across or less
    T1mi – the tumour is 0.1cm across or less
    T1a – the tumour is more than 0.1 cm but not more than 0.5 cm
    T1b – the tumour is more than 0.5 cm but not more than 1 cm
    T1c – the tumour is more than 1 cm but not more than 2 cm
T2 – The tumour is more than 2 centimetres, but no more than 5 centimetres across
T3 – The tumour is bigger than 5 centimetres across
T4 
    T4a – The tumour has spread into the chest wall
    T4b – The tumour has spread into the skin and the breast may be swollen
    T4c – The tumour has spread to both the skin and the chest wall
    T4d – Inflammatory carcinoma – this is a cancer in which the overlying skin is red, swollen and painful to the touch
","NX means that the lymph nodes cannot be assessed (for example, if they were previously removed)
N0 – No cancer cells found in any nearby nodes

Isolated tumour cells (ITCs) are small clusters of cancer cells less than 0.2 mm across, or a single tumour cell, or a cluster of fewer than 200 cells in one area of a lymph node. Lymph nodes containing only isolated tumour cells are not counted as positive lymph nodes

N1 – Cancer cells are in the lymph nodes in the armpit but the nodes are not stuck to surrounding tissues

pN1mi – One or more lymph nodes contain areas of cancer cells called micrometastases that are larger than 0.2mm or contain more than 200 cancer cells but are less than 2mm

N2 is divided into 2 groups

    N2a – there are cancer cells in the lymph nodes in the armpit, which are stuck to each other and to other structures
    N2b – there are cancer cells in the lymph nodes behind the breast bone (the internal mammary nodes), which have either been seen on a scan or felt by the doctor. There is no evidence of cancer in lymph nodes in the armpit

N3 is divided into 3 groups

    N3a – there are cancer cells in lymph nodes below the collarbone
    N3b – there are cancer cells in lymph nodes in the armpit and behind the breast bone
    N3c – there are cancer cells in lymph nodes above the collarbone
","MX - Distant metastasis (M) cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis",Breast
11,Oral cavity,"TX 	Primary tumour cannot be assessed
T0 	No evidence of primary tumour
Tis 	Carcinoma in situ
T1 	Tumour 2 cm or less in greatest dimension
T2 	Tumour more than 2 cm but not more than 4 cm in greatest dimension
T3 	Tumour more than 4 cm in greatest dimension
T4a (lip) 	Tumour invades through cortical bone, inferior alveolar nerve, floor of mouth, or skin (chin or nose)
T4a (oral cavity) 	Tumour invades through cortical bone, into deep/extrinsic muscle of tongue (genioglossus, hyoglossus, palatoglossus, and styloglossus), maxillary sinus, or skin of face
T4b (lip and oral cavity) 	Tumour invades masticator space, pterygoid plates, or skull base; or encases internal carotid artery
","NX 	Regional lymph nodes cannot be assessed
N0 	No regional lymph node metastasis
N1 	Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension
N2 	Metastasis as specified in N2a, 2b, 2c below
N2a 	Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension
N2b 	Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension
N2c 	Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension
N3 	Metastasis in a lymph node more than 6 cm in greatest dimension","MX 	Distant metastasis cannot be assessed
M0 	No distant metastasis
M1 	Distant metastasis",Head and Neck
12,Thyroid,"TX	Primary tumor cannot be assessed
T0	No evidence of primary tumor is found
T1	Tumor size ≤ 2 cm in greatest dimension and is limited to the thyroid
T1a	Tumor ≤ 1 cm, limited to the thyroid
T1b	Tumor > 1 cm but ≤ 2 cm in greatest dimension, limited to the thyroid
T2	Tumor size > 2 cm but ≤ 4 cm, limited to the thyroid.
T3	Tumor size >4 cm, limited to the thyroid or any tumor with minimal extrathyroidal extension (eg, extension to sternothyroid muscle or perithyroid soft tissues)
T4a	Moderately advanced disease; tumor of any size extending beyond the thyroid capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve
T4b	Very advanced disease; tumor invades prevertebral fascia or encases carotid artery or mediastinal vessel
All anaplastic carcinomas are considered stage IV:
T4a	Intrathyroidal anaplastic carcinoma
T4b	Anaplastic carcinoma with gross extrathyroid extension","NX	Regional nodes cannot be assessed
N0	No regional lymph node metastasis
N1	Regional lymph node metastasis
N1a	Metastases to level VI (pretracheal, paratracheal, and prelaryngeal/Delphian lymph nodes)
N1b	Metastases to unilateral, bilateral, or contralateral cervical (levels I, II, III, IV, or V) or retropharyngeal or superior mediastinal lymph nodes (level VII)
","MX 	Distant metastasis cannot be assessed
M0 	No distant metastasis
M1 	Distant metastasis",Head and Neck
13,Paranasal sinus (maxilla),"TX Primary tumor cannot be assessed
T0 No evidence of primary tumor
Tis Carcinoma in situ
T1 Tumor limited to maxillary sinus mucosa with no erosion or destruction of bone
T2 Tumor causing bone erosion or destruction, including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of the maxillary sinus and pterygoid plates
T3 Tumor invades any of the following: bone of the posterior wall of the maxillary sinus, subcutaneous tissues, floor or medial wall of the orbit, pterygoid fossa, ethmoid sinuses
T4a Moderately advanced local disease

    Tumor invades the anterior orbital contents, skin of the cheek, pterygoid plates, infratemporal fossa, cribriform plate, sphenoid or frontal sinuses 

T4b Very advanced local disease

    Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve (V2), nasophary","NX Regional nodes cannot be assessed
N0 No regional lymph node metastasis
N1 Metastasis in a single ipsilateral lymph node =3cm in greatest dimension
N2 Metastasis in a single ipsilateral lymph node >3cm but not more than 6cm in greatest dimension; or in multiple ipsilateral lymph nodes, none >6cm in greatest dimension; or in bilateral or contralateral lymph nodes, none >6cm in greatest dimension
N2a Metastasis in a single ipsilateral lymph node >3cm but not more than 6cm in greatest dimension
N2b Metastasis in multiple ipsilateral lymph nodes, none >6cm in greatest dimension
N2c Metastasis in bilateral or contralateral lymph nodes, none >6cm in greatest dimension
N3 Metastasis in a lymph node >6cm in greatest dimension","MX 	Distant metastasis cannot be assessed
M0 	No distant metastasis
M1 	Distant metastasis",Head and Neck
14,Paranasal sinus (ethmoid) ,"TX Primary tumor cannot be assessed
T0 No evidence of primary tumor
Tis Carcinoma in situ
T1 Tumor restricted to any 1 subsite, with or without bony invasion
T2 Tumor invading 2 subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion
T3 Tumor extends to invade the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate
T4a Moderately advanced local disease

    Tumor invades any of the following: anterior orbital contents, skin of the nose or cheek, minimal extension to the anterior cranial fossa, pterygoid plates, sphenoid or frontal sinuses 

T4b Very advanced local disease

    Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve (V2), nasopharynx, or clivus ","NX Regional nodes cannot be assessed
N0 No regional lymph node metastasis
N1 Metastasis in a single ipsilateral lymph node =3cm in greatest dimension
N2 Metastasis in a single ipsilateral lymph node >3cm but not more than 6cm in greatest dimension; or in multiple ipsilateral lymph nodes, none >6cm in greatest dimension; or in bilateral or contralateral lymph nodes, none >6cm in greatest dimension
N2a Metastasis in a single ipsilateral lymph node >3cm but not more than 6cm in greatest dimension
N2b Metastasis in multiple ipsilateral lymph nodes, none >6cm in greatest dimension
N2c Metastasis in bilateral or contralateral lymph nodes, none >6cm in greatest dimension
N3 Metastasis in a lymph node >6cm in greatest dimension","MX 	Distant metastasis cannot be assessed
M0 	No distant metastasis
M1 	Distant metastasis",Head and Neck
15,Nasal cavity,"TX Primary tumor cannot be assessed
T0 No evidence of primary tumor
Tis Carcinoma in situ
T1 Tumor restricted to any 1 subsite, with or without bony invasion
T2 Tumor invading 2 subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion
T3 Tumor extends to invade the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate
T4a Moderately advanced local disease

    Tumor invades any of the following: anterior orbital contents, skin of the nose or cheek, minimal extension to the anterior cranial fossa, pterygoid plates, sphenoid or frontal sinuses 

T4b Very advanced local disease

    Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve (V2), nasopharynx, or clivus ","NX Regional nodes cannot be assessed
N0 No regional lymph node metastasis
N1 Metastasis in a single ipsilateral lymph node =3cm in greatest dimension
N2 Metastasis in a single ipsilateral lymph node >3cm but not more than 6cm in greatest dimension; or in multiple ipsilateral lymph nodes, none >6cm in greatest dimension; or in bilateral or contralateral lymph nodes, none >6cm in greatest dimension
N2a Metastasis in a single ipsilateral lymph node >3cm but not more than 6cm in greatest dimension
N2b Metastasis in multiple ipsilateral lymph nodes, none >6cm in greatest dimension
N2c Metastasis in bilateral or contralateral lymph nodes, none >6cm in greatest dimension
N3 Metastasis in a lymph node >6cm in greatest dimension","MX 	Distant metastasis cannot be assessed
M0 	No distant metastasis
M1 	Distant metastasis",Head and Neck
16,Larynx (supraglottis),"T1: The tumor is located in a single area above the vocal folds that does not affect the movement of the vocal folds.

T2: The tumor started in the supraglottis but has spread to the mucous membranes that line other areas, such as the base of the tongue.

T3: The tumor is limited to the larynx with vocal fold involvement and/or has spread to surrounding tissue.

T4a: The tumor has spread through the thyroid cartilage and/or the tissue beyond the larynx.

T4b: The tumor has spread to the area in front of the spine (prevertebral space), chest area, or encases the arteries.
","NX: The regional lymph nodes cannot be evaluated.
N0: There is no evidence of cancer in the regional nodes.
N1: The cancer has spread to a single node on the same side as the primary tumor, and the cancer found in the node is 3 cm or smaller.
N2: Describes any of the following conditions:
    N2a: The cancer has spread to a single lymph node on the same side as the primary tumor and is larger than 3 cm, but not larger than 6 cm.
    N2b: The cancer has spread to more than one lymph node on the same side as the primary tumor, and none measure larger than 6 cm.
    N2c: The cancer has spread to more than one lymph node on either side of the body, and none measure larger than 6 cm.
N3: The cancer found in the lymph nodes is larger than 6 cm.","MX 	Distant metastasis cannot be assessed
M0 	No distant metastasis
M1 	Distant metastasis",Head and Neck
17,Larynx (glottis)," T1: The tumor is limited to the vocal folds, but it does not affect the movement of the folds.

T1a: The tumor is only in the right or left vocal fold.

T1b: The tumor is in both vocal folds.

T2: The tumor has spread to the supraglottis and/or the subglottis. T2 also describes a tumor that affects the movement of the vocal fold, without paralyzing the fold.

T3: The tumor is limited to the larynx and paralyzes at least one of the vocal folds.

T4a: The tumor has spread to the thyroid cartilage and/or the tissue beyond the larynx.

T4b: The tumor has spread to the area in front of the spine (prevertebral space), chest area, or encases the arteries.","NX: The regional lymph nodes cannot be evaluated.
N0: There is no evidence of cancer in the regional nodes.
N1: The cancer has spread to a single node on the same side as the primary tumor, and the cancer found in the node is 3 cm or smaller.
N2: Describes any of the following conditions:
    N2a: The cancer has spread to a single lymph node on the same side as the primary tumor and is larger than 3 cm, but not larger than 6 cm.
    N2b: The cancer has spread to more than one lymph node on the same side as the primary tumor, and none measure larger than 6 cm.
    N2c: The cancer has spread to more than one lymph node on either side of the body, and none measure larger than 6 cm.
N3: The cancer found in the lymph nodes is larger than 6 cm.","MX 	Distant metastasis cannot be assessed
M0 	No distant metastasis
M1 	Distant metastasis",Head and Neck
18,Larynx (subglottis)," T1: The tumor is limited to the subglottis.

T2: The tumor has spread to the vocal folds and may or may not affect the movement of the folds.

T3: The tumor is limited to the larynx and affects the vocal folds.

T4a: The tumor has spread to the cricoids, the ring-shaped cartilage near the bottom of the larynx, or thyroid cartilage and/or the tissue beyond the larynx.

T4b: The tumor has spread to the area in front of the spine, chest area, or encases the arteries.","NX: The regional lymph nodes cannot be evaluated.
N0: There is no evidence of cancer in the regional nodes.
N1: The cancer has spread to a single node on the same side as the primary tumor, and the cancer found in the node is 3 cm or smaller.
N2: Describes any of the following conditions:
    N2a: The cancer has spread to a single lymph node on the same side as the primary tumor and is larger than 3 cm, but not larger than 6 cm.
    N2b: The cancer has spread to more than one lymph node on the same side as the primary tumor, and none measure larger than 6 cm.
    N2c: The cancer has spread to more than one lymph node on either side of the body, and none measure larger than 6 cm.
N3: The cancer found in the lymph nodes is larger than 6 cm.","MX 	Distant metastasis cannot be assessed
M0 	No distant metastasis
M1 	Distant metastasis",Head and Neck
19,Larynx (hypopharynx)," T1: The tumor is small, no larger than 2 centimeters (cm), and is limited to a single site in the lower throat.

T2: The tumor involves more than one site in the lower throat, but does not touch the voice box, or the tumor measures between 2 cm and 4 cm.

T3: The tumor is larger than 4 cm or has spread to the larynx.

T4a: The tumor has spread into nearby structures, such as the thyroid, the arteries that carry blood to the brain, or the esophagus.

T4b: The tumor has spread to the prevertebral fascia (space in front of the spinal cord), encases the arteries, or involves mediastinal (chest-area) structures.","NX: The regional lymph nodes cannot be evaluated.
N0: There is no evidence of cancer in the regional nodes.
N1: The cancer has spread to a single node on the same side as the primary tumor, and the cancer found in the node is 3 cm or smaller.
N2: Describes any of the following conditions:
    N2a: The cancer has spread to a single lymph node on the same side as the primary tumor and is larger than 3 cm, but not larger than 6 cm.
    N2b: The cancer has spread to more than one lymph node on the same side as the primary tumor, and none measure larger than 6 cm.
    N2c: The cancer has spread to more than one lymph node on either side of the body, and none measure larger than 6 cm.
N3: The cancer found in the lymph nodes is larger than 6 cm.","MX 	Distant metastasis cannot be assessed
M0 	No distant metastasis
M1 	Distant metastasis",Head and Neck
20,Melanoma,"TX 
Primary tumor cannot be assessed (for example, curettaged
or severely regressed melanoma)
T0 
No evidence of primary tumor

T1 
Melanomas 1.0 mm or less in thickness
T2 
Melanomas 1.01ﾖ2.0 mm
T3 
Melanomas 2.01ﾖ4.0 mm
T4 
Melanomas more than 4.0 mm","NX	Patients in whom the regional nodes cannot be assessed (ie, previously removed for another reason)
N0	No regional metastases detected
N1-3	Regional metastases based upon number of metastatic nodes and presence or absence of intralymphatic metastases (in transit or satellite metastases)
N1	1 lymph node

    N1a: Micrometastases
    N1b: Macrometastases

N2	2 or 3 lymph nodes

    N2a: Micrometastases
    N2b: Macrometastases
    N2c: In-transit met(s)/satellite(s) without metastatic lymph nodes

N3	≥ 4 metastatic lymph nodes, or matted lymph nodes, or in-transit met(s)/satellite(s) with metastatic lymph node(s)",,Skin
21,Ovary,"TX     Primary tumor cannot be assessed
T0     No evidence of primary tumor
T1     Tumor limited to the ovaries (one or both)
T1a   Tumor limited to one ovary; capsule intact, no tumor on ovarian surface; no malignant cells in ascites or peritoneal washings
T1b   Tumor limited to both ovaries; capsules intact, no tumor on ovarian surface; no malignant cells in ascites or peritoneal washings
T1c  Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings
T2 Tumor involves one or both ovaries with pelvic extension
T2a   Extension and/or implants on the uterus and/or tube(s); no malignant cells in ascites or peritoneal washings
T2b   Extension to and/or implants in other pelvic tissues; no malignant cells in ascites or peritoneal washings
T2c  Pelvic extension and/or implants (T2a or T2b) with malignant cells in ascites or peritoneal washings
T3  Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis
T3a   Microscopic peritoneal metastasis beyond the pelvis (no macroscopic tumor)
T3b  Macroscopic peritoneal metastasis beyond the pelvis 2 cm or less in greatest dimension
T3c  Macroscopic peritoneal metastasis beyond the pelvis >2 cm in greatest dimension and/or regional lymph node metastasis","NX     Regional lymph nodes cannot be assessed
N0     No regional lymph node metastasis
N1     Regional lymph node metastasis",,Gyecologic
22,Testis,"TX Primary tumor cannot be assessed
T0 No evidence of primary tumor
Tis Intratubular germ cell neoplasia
T1 Tumor limited to the testis and epididymis or tumor invasion into the tunica albuginea only
T2 Tumor extending through the tunica albuginea with involvement of the tunica vaginalis
T3 Tumor invades the spermatic cord
T4 Tumor invades the scrotum","NX Regional lymph nodes cannot be assessed
N0 No regional lymph node metastasis
N1 Metastases to single or multiple lymph nodes, each < 2 cm in size
N2 Metastases to single or multiple lymph nodes, >2 cm but < 5 cm in size
N3 Metastases to lymph node, >5 cm in greatest dimension","MX Distant metastasis cannot be assessed
M0 No distant metastasis
M1 Distant metastasis
M1a Nonregional nodal or pulmonary metastasis
M1b Distant metastasis other than to nonregional lymph nodes and lungs",Genitourinary
23,Bone,"TX Primary tumor cannot be assessed
TO No evidence of primary tumor
Tl Tumor 8 cm or less in greatest dimension
T2 Tumor more than 8 cm in greatest dimension
T3 Discontinuous tumors in the primary bone site","NX Regional lymph nodes cannot be assessed
NO No regional lymph node metastasis
Nl Regional lymph node metastasis","M1X Distant metastasis cannot be assessed
MO No distant metastasis
Ml Distant metastasis
Mla Lung
Mlb Other distant sites",Musculoskeletal
24,Soft tissue sarcoma,"TX Primary tumor cannot be assessed
TO No evidence of primary tumor
Tl Tumor 5 cm or less in greatest dimension
Tla superficial tumor
Tlb deep tumor
T2 Tumor more than 5 cm in greatest dimension
T2a superficial tumor
T2b deep tumor","NX Regional lymph node1> cannot be assessed
NO No regional lymph node metastasis
N l * Regional lymph node metastasis","MX Distant metastasis cannot be assessed
MO No distant metastasis
Ml Distant metastasis",Musculoskeletal
25,Vulva,"TX   Primary tumor cannot be assessed
T0   No evidence of a primary tumor
T1a (IA) Lesions ?2 cm, confined to the vulva or perineum and with stromal invasion ?1 mmb
T1b (IB) Lesions >2 cm or any size with stromal invasion >1 mm, confined to the vulva or perineum
T2 (II) Tumor of any size with extension to adjacent perineal structures (distal third of the urethra, distal third of the vagina, anal involvement)
T3 (IVA) Tumor of any size with extension to any of the following proximal two thirds of the urethra, proximal two thirds of the vagina, bladder mucosa, or rectal mucosa or fixed to pelvic bone","NX   Regional lymph nodes cannot be assessed
N0   No regional lymph node metastasis
N1   1 or 2 regional (inguinofemoral) lymph nodes with the following features (see N1a, N1b)
N1a (IIIA) 1 or 2 lymph node metastases, each < 5 mm
N1b (IIIA) 1 regional lymph node metastasis ?5 mm
N2   Regional (inguinofemoral) lymph nodes with the following features (see N2a, N2b, N2c)
N2a (IIIB) 3 or more lymph node metastases, each < 5 mm
N2b (IIIB) 2 or more regional lymph node metastases ?5 mm
N2c (IIIC) Regional lymph node metastasis with extracapsular spread
N3 (IVA) Fixed or ulcerated regional lymph node metastasis","M0   No distant metastasis
M1 (IVB) Distant metastasis (including to pelvic lymph nodes)",Gyecologic
26,Liver,"TX Primary tumor cannot be assessed
T0 No evidence of primary tumor
T1 Solitary tumor without vascular invasion
T2 Solitary tumor with vascular invasion or multiple tumors, none > 5 cm
T3a Multiple tumors > 5 cm
T3b Single tumor or multiple tumors of any size involving a major branch of the portal or hepatic vein
T4 Tumor(s) with direct invasion of adjacent organs other than gallbladder or with visceral peritoneum","NX Regional lymph nodes cannot be assessed
N0 No regional lymph node metastasis
N1 Regional lymph node metastasis","MX Distant metastasis cannot be assessed
MO No distant metastasis
Ml Distant metastasis",Digestive system
27,Gallbladder,"TX - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ
T1 - Tumor invades lamina propria or muscle layer
    T1a - Tumor invades lamina propria
    T1b - Tumor invades muscle layer
T2 - Tumor invades perimuscular connective tissue; no extension beyond serosa or into liver
T3 - Tumor perforates the serosa (visceral peritoneum) and/or directly invades the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts
T4 - Tumor invades main portal vein or hepatic artery or invades multiple extrahepatic organs or structures","    NX - Regional lymph nodes cannot be assessed
    N0 - No metastases in regional lymph nodes
    N1 - Metastases to regional lymph nodes along the cystic duct, common bile duct, hepatic artery, and/or portal vein
    N2 - Metastases to periaortic, pericaval, superior mesenteric artery, and/or celiac artery lymph nodes","MX Distant metastasis cannot be assessed
MO No distant metastasis
Ml Distant metastasis",Digestive system
28,Pancreas,"TX Primary tumor cannot be assessed
T0 No evidence of primary tumor
Tis Carcinoma in situ
T1 Tumor limited to the pancreas, ? 2 cm in greatest dimension
T2 Tumor limited to the pancreas, > 2 cm in greatest dimension
T3 Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery
T4 Tumor involves the celiac axis or the superior mesenteric artery (unresectable primary tumor)","NX Regional lymph nodes cannot be assessed
N0 No regional lymph node metastasis
N1 Regional lymph node metastasis","MX Distant metastasis cannot be assessed
MO No distant metastasis
Ml Distant metastasis",Digestive system
